Agent | Mechanism of Action | Route | Effect on PDPH | Adverse Effects |
Opioids | Interact with opioid receptors in the central nervous system. | Oral/IV | Pain relief | Nausea and Vomiting |
Caffeine | Central nervous system stimulant, reversibly blocks cerebral adenosine receptors which lead to vasoconstriction of dilated cerebral blood vessels. | Oral/IV (300 - 500 mg) once or twice daily. Single oral dose for mild PDPH was proved to be safe [47] . Caffeine Sodium Benzoate as an IV Bolus/Infusion was proved to be 75% - 80% effective [48] | Temporary pain relief | Return of headache 48 hr after the IV administered dose |
Sumatriptan | Serotonin type 1-d receptor agonist, vasoconstriction of intracranial blood vessels. | Subcutaneous | Variable results: a few case reports have reported improvement of symptoms [49] while clinical trials have proved inefficacy [50] [51] | Pain at the site of injection Chest tightness Caution in patients with Ischemic Heart Disease Expensive drug |